DalyAB, BoughtonCK, NwokoloM, et al.Fully automated closed-loop insulin delivery in adults with type 2 diabetes: An open-label, single-center, randomized crossover trial. Nat Med, 2023; In Press; doi: 10.1038/s41591-022-02144-z
2.
BoughtonCK, DalyA, ThabitH, et al.Day-to-day variability of insulin requirements in the inpatient setting: Observations during fully closed-loop insulin delivery. Diabetes Obes Metab, 2021; 23:1978–1982; doi: 10.1111/dom.14396
3.
RuanY, ThabitH, LeelarathnaL, et al.Variability of insulin requirements over 12 weeks of closed-loop insulin delivery in adults with type 1 diabetes. Diabetes Care, 2016; 39(5):830–832; doi: 10.2337/dc15-2623
4.
HarperR, BashanE, BisgaierSG, et al.Temporary reductions in insulin requirements are associated with hypoglycemia in type 2 diabetes. Diabetes Technol Ther, 2018; 20(12):817–824; doi: 10.1089/dia.2018.0266
5.
CahnA, MiccoliR, DardanoA, et al.New forms of insulin and insulin therapies for the treatment of type 2 diabetes. Lancet Diabetes Endocrinol, 2015; 3(8):638–652; doi: 10.1016/S2213-8587(15)00097-2
